• Blog
  • Publications
  • News
  • Contact Us
Visit Us On FacebookVisit Us On Linkedin
  • Blog
  • Publications
  • News
  • Contact Us
Owen Barry Pharmeceuticals, epilepsy Owen Barry Pharmeceuticals, epilepsy
  • About
  • Matthew’s Story
  • The Team
    • Founders
      • Michael Poulter Ph.D.
      • John Poulter B.A., C.F.A.
    • Management
      • Lawrence Mahan Ph.D.
      • Michael Rogawski, MD, PhD
    • Board of Directors
      • John Poulter B.A., C.F.A.
      • Lawrence Mahan Ph.D.
      • Caroline Schild-Poulter, Ph.D.
      • Rod Prat B.A., M.B.A.
    • Scientific and Clinical Advisory
      • Pavel Klein, MD
      • Peter Carlen, MD, FRCPC
      • Anthony Krantis Ph.D.
      • Tony Durst Ph.D.
  • Technology
  • Investors
  • About
  • Matthew’s Story
  • The Team
    • Founders
      • Michael Poulter Ph.D.
      • John Poulter B.A., C.F.A.
    • Management
      • Lawrence Mahan Ph.D.
      • Michael Rogawski, MD, PhD
    • Board of Directors
      • John Poulter B.A., C.F.A.
      • Lawrence Mahan Ph.D.
      • Caroline Schild-Poulter, Ph.D.
      • Rod Prat B.A., M.B.A.
    • Scientific and Clinical Advisory
      • Pavel Klein, MD
      • Peter Carlen, MD, FRCPC
      • Anthony Krantis Ph.D.
      • Tony Durst Ph.D.
  • Technology
  • Investors
29 May 2025

Board Changes

by Larry Mahan | posted in: Uncategorized | 0

TORONTO, ONTARIO – May 28, 2025 – OB Pharmaceuticals, Inc. announces the retirement of two founding Board members, Andrew Clarke … Read More

7 Dec 2020

OB Pharmaceuticals announces its poster presentation at the annual meeting of the American Epilepsy Society

by Wayland | posted in: American Epilepsy Society, Events, Uncategorized | 0

TORONTO, ONTARIO – December 4, 2020 – OB Pharmaceuticals, Inc., announced today the company will present its poster on its … Read More

28 Feb 2020

OB Pharmaceuticals announces the addition of two new members.

by Wayland | posted in: Uncategorized | 0

LONDON, ONTARIO February 25, 2020 —  OB Pharmaceuticals announces the addition of two new members to its Scientific and Clinical … Read More

5 Nov 2019

OB Pharmaceuticals CSO, Dr. Michael Poulter in the News

by Wayland | posted in: Michael Poulter, Uncategorized | 0

LONDON, ONTARIO May 16, 2019 — OB Pharmaceuticals CSO, Dr. Michael Poulter in the News. Dr. Michael Poulter, CSO was … Read More

5 Nov 2019

Dr. Larry Mahan, CEO of OB Pharmaceuticals, attended the JP Morgan Healthcare Conference

by Wayland | posted in: Larry Mahan, Uncategorized | 0

LONDON, ONTARIO January 12, 2019 — Dr. Larry Mahan, CEO of OB Pharmaceuticals, attended the JP Morgan Healthcare Conference week … Read More

5 Nov 2019

OB Pharmaceuticals has been granted utility patent US 10,087,138

by Wayland | posted in: Uncategorized | 0

LONDON, ONTARIO October 2, 2018 — OB Pharmaceuticals has been granted utility patent US 10,087,138 from the U.S. Patent and … Read More

4 Mar 2019

Dr. Michael Poulter, CSO of OB Pharmaceuticals to present at Eilat XIV.

by Wayland | posted in: Eilat XIV, Michael Poulter, Uncategorized | 0

LONDON, ONTARIO May 2, 2018 — OB Pharmaceuticals was invited to present the details of its drug development program of … Read More

4 Mar 2019

Dr. Larry Mahan, VP Business Development to present at Biotech Showcase 2018

by Wayland | posted in: Biotech Showcase, Larry Mahan, Uncategorized | 0

LONDON, ONTARIO January 2, 2018 — Dr. Larry Mahan attended BioTech Showcase 2018 during JP Morgan week in San Francisco … Read More

4 Mar 2019

OB Pharmaceuticals to attend BioEurope Spring 2017

by Wayland | posted in: BioEurope, Uncategorized | 0

LONDON, ONTARIO March 10, 2017 — Representatives from OB Pharmaceuticals attended BioEurope Spring 2017 in Barcelona, Spain, March 20-22 to … Read More

Recent Posts

  • Board Changes
  • OB Pharmaceuticals announces its poster presentation at the annual meeting of the American Epilepsy Society
  • OB Pharmaceuticals announces the appointment of Dr. Michael Rogawski
  • New Patents Awarded
  • Biotechnology Innovation Organization’s International Convention

Social Media

Visit Us On FacebookVisit Us On Linkedin

Site Designed By Wayland Robinson Design & Multimedia.

Posts

  • Disclaimer
  • Terms Of Use
  • Privacy Statement

Copyright 2021 O.B. Pharmaceuticals. All Rights Reserved.